Optimization strategies for antimicrobial peptides in dental caries prevention and management: from emerging mechanisms of action to clinical translation
Open Access
- 14 August 2026
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 17, 1899522
Abstract
Dental caries remains a prevalent global health burden driven by dysbiosis of the biofilm microbiome. Antimicrobial peptides (AMPs), characterized by a low risk of resistance development and immunomodulatory potential, have emerged as promising alternatives to conventional antimicrobials; however, their clinical translation is still constrained by physiological instability, cytotoxicity, limited oral substantivity, and substantial regulatory and economic barriers. This review systematically summarizes recent advances in the mechanisms of action, rational design, and translational strategies of AMPs for the prevention and management of dental caries. The article first outlines updated mechanistic concepts, highlighting a shift from the classical stable pore-forming model toward transient water channel formation and lipid flip-flop models, and further discusses microbiome-oriented ecological modulation strategies aimed at preserving beneficial commensals and suppressing cariogenic dysbiosis. In addition, structure–activity relationships are examined in depth, with emphasis on how diverse optimization approaches can balance peptide activity, toxicity, stability, selectivity, and manufacturability. The review also delineates the major barriers that impede clinical translation, including production cost, GMP-compatible manufacturing, batch consistency, delivery format, and regulatory definability. Potential strategies are discussed, including molecular farming in plant bioreactors, recombinant or synthetic production platforms, covalent immobilization, in situ biomimetic systems, and pH-responsive delivery systems for improving local bioavailability within cariogenic microenvironments. Finally, we emphasize that most current evidence remains preclinical and that no generalizable clinical framework for AMP-based caries prevention has yet been established. Future development should integrate mechanism-guided design, microbiome-level evaluation, standardized safety and efficacy endpoints, scalable manufacturing, and controlled clinical validation.Keywords
This publication has 151 references indexed in Scilit:
- Constructing two bifunctional tooth-targeting antimicrobial peptides for caries management: an in vitro studyClinical Oral Investigations, 2024
- Combined Phase 1/2a Initial Clinical Safety Trials and Proof‐of‐Concept Assessment of a Novel Antimicrobial Peptide KSL‐W Anti‐Plaque Chewing GumClinical and Experimental Dental Research, 2024
- The amphipathic design in helical antimicrobial peptidesChemMedChem, 2024
- Encapsulation of a novel peptide derived from histatin-1 in liposomes against initial enamel caries in vitro and in vivoClinical Oral Investigations, 2023
- Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implicationsMedcomm, 2023
- The effect of tailing lipidation on the bioactivity of antimicrobial peptides and their aggregation tendencyAggregate, 2023
- Hydrophobic and antimicrobial dentin: A peptide-based 2-tier protective system for dental resin composite restorationsActa Biomaterialia, 2019
- A tooth-binding antimicrobial peptide to prevent the formation of dental biofilmJournal of Materials Science: Materials in Medicine, 2019
- The synthetic human beta-defensin-3 C15 peptide exhibits antimicrobial activity against Streptococcus mutans, both alone and in combination with dental disinfectantsJournal of Microbiology, 2017
- Effects of net charge and the number of positively charged residues on the biological activity of amphipathic α‐helical cationic antimicrobial peptidesPeptide Science, 2008